Matt Chavez
About Matt Chavez
Matt Chavez is the Vice President of Life Sciences at Komodo Health, with extensive experience in various therapeutic areas and sectors within the healthcare industry.
Komodo Health Vice President, Life Sciences
Matt Chavez currently holds the position of Vice President, Life Sciences at Komodo Health in the New York City Metropolitan Area. In this role, he leads the commercial aspects of innovative ventures across global markets. His work focuses on leveraging science, technology, and healthcare to reduce the global burden of disease.
Previous Experience at Komodo Health
Prior to his current role, Matt Chavez served as Area Vice President, Life Sciences Intermediaries - Data & Technology Partnerships at Komodo Health. He held this position from 2021 to 2023 in the New York City Metropolitan Area. In this capacity, he was responsible for building and managing data and technology partnerships within the life sciences intermediaries sector.
Business Development Roles
Before his tenure at Komodo Health, Matt Chavez contributed as a Business Development professional in the Life Sciences sector at McKesson from 2020 to 2021. Additionally, he engaged in Account Management for Life Sciences at GLG (Gerson Lehrman Group) between 2018 and 2020. These roles were based in the San Francisco Bay Area, Austin, TX, and the New York City Metropolitan Area.
Educational Background
Matt Chavez holds a Master of Science (MS) in Technology Commercialization from the Texas McCombs School of Business and a Graduate Certificate in Strategic Healthcare Policy Management from The Washington Campus. He also obtained an MBA in Healthcare & Strategy from Lamar University and a Bachelor’s Degree in Healthcare Administration from Texas State University.
Industry Experience and Leadership
Matt Chavez has extensive experience across various therapeutic and disease areas, including Oncology, Hematology, Rare Disease, Immunology, Infectious Disease, among others. His sector experience encompasses Biotechnology, Pharmaceutical, Medical Device, Diagnostics, Genomics, and Digital Health. He has been recognized as a Top 25 Healthcare Technology Leader, reflecting his significant contributions to the field.